SCHEMBL5291997

SCHEMBL5291997

O=C(Nc1ccc(-c2c[c]ccc2)cc1)c1nnc(Nc2ccccc2F)o1

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3541491 0.90 DGAT1 (1.00) DGAT1
SCHEMBL5308194 0.89 DGAT1 (0.67) DGAT1
SCHEMBL3544242 0.84 DGAT1 (0.85) DGAT1
SCHEMBL3539845 0.83 DGAT1 (1.00) DGAT1
SCHEMBL3540480 0.82 DGAT1 (0.81) DGAT1
SCHEMBL3537813 0.81 DGAT1 (1.00) DGAT1
SCHEMBL3547198 0.81 DGAT1 (0.82) DGAT1
SCHEMBL3542950 0.81 DGAT1 (0.79) DGAT1
SCHEMBL3543868 0.79 DGAT1 (1.00) DGAT1
SCHEMBL3541703 0.78 DGAT1 (0.74) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833806-A1 OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006064189-A1 OXADIAZOLE DERIVATIVES AS DGAT INHIBITORS ASTRAZENECA AB (SE) 2006-06-22 WO disclosed